martes, 23 de diciembre de 2014

National Guideline Clearinghouse | Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.

FULL-TEXT ►



National Guideline Clearinghouse | Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.







National Institute for Health and Care Excellence (NICE)



National Guideline Clearinghouse (NGC)



Guideline Title


Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.


Bibliographic Source(s)


National Institute for Health and Care Excellence. Dimethyl fumarate for treating relapsing-remitting multiple sclerosis. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Aug. 61 p. (Technology appraisal guidance; no. 320). 


Guideline Status


This is the current release of the guideline.
This guideline meets NGC's 2013 (revised) inclusion criteria.
National Guideline Clearinghouse | Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.

No hay comentarios:

Publicar un comentario